Trademark: 88729361
Word

Status
Dead
Status Code
606
Status Date
Monday, March 6, 2023
Serial Number
88729361
Mark Type
2000
Filing Date
Monday, December 16, 2019
Published for Opposition
Tuesday, June 2, 2020
Abandoned Date
Monday, March 6, 2023

Trademark Owner History
MORNING LIGHT IP, LLC - Owner At Publication

Classifications
40 Manufacturing services for others in the fields of gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals; Manufacturing services for others in the fields of mammalian cell banks, plasmids, adenovirus, adeno-associated virus (AAV), bacteriophage, lentivirus, retroviruses and other viruses found in humans and animals; Manufacturing process consulting
45 Regulatory compliance consulting in the fields of pharmaceuticals, medicines, biopharmaceuticals, and gene therapy
42 Research and development services in the fields of gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals; Consulting services in the fields of research and development for gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals; Research and development of new products for others; Process development services in the nature of research and development of gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals; Scientific research and technical research services, namely, production of cell lines for others using lentivirus technology; Scientific research and technical research services relating to producing, assaying and purifying recombinant or manipulated lentivirus; Scientific and technical consulting services relating to producing, assaying, and purifying adenovirus, adeno-associated virus (AAV), bacteriophage, lentivirus, retroviruses and other viruses found in humans and animals; advisory services relating to research and development of gene therapy products and biopharmaceuticals; manufacturing support services for others, namely, cGMP (Current Good Manufacturing Practice) quality control testing in support of biopharmaceutical development and manufacturing; Quality control for others; Quality management services, namely, quality evaluation and analysis, quality assurance, and quality control, in the fields of gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals; Material testing; Product quality testing; Scientific laboratory services; Scientific research
The mark consists of four vertical lines of varying lengths, followed to the right by a contiguous line curling around to form an abstract shape.
Color is not claimed as a feature of the mark.

Trademark Events
Mar 6, 2023
Abandonment Notice E-Mailed - No Use Statement Filed
Mar 6, 2023
Abandonment - No Use Statement Filed
Jun 30, 2022
Notice Of Approval Of Extension Request E-Mailed
Jun 28, 2022
Sou Extension 4 Granted
Jun 28, 2022
Sou Extension 4 Filed
Jun 28, 2022
Sou Teas Extension Received
Jan 28, 2022
Notice Of Approval Of Extension Request E-Mailed
Jan 26, 2022
Sou Extension 3 Granted
Jan 26, 2022
Sou Extension 3 Filed
Jan 26, 2022
Sou Teas Extension Received
Jun 30, 2021
Notice Of Approval Of Extension Request E-Mailed
Jun 28, 2021
Sou Extension 2 Granted
Jun 28, 2021
Sou Extension 2 Filed
Jun 28, 2021
Sou Teas Extension Received
Dec 3, 2020
Notice Of Approval Of Extension Request E-Mailed
Dec 1, 2020
Sou Extension 1 Granted
Dec 1, 2020
Sou Extension 1 Filed
Dec 1, 2020
Sou Teas Extension Received
Jul 28, 2020
Noa E-Mailed - Sou Required From Applicant
Jun 2, 2020
Official Gazette Publication Confirmation E-Mailed
Jun 2, 2020
Published For Opposition
May 13, 2020
Notification Of Notice Of Publication E-Mailed
Apr 28, 2020
Assigned To Lie
Apr 22, 2020
Approved For Pub - Principal Register
Apr 22, 2020
Teas/Email Correspondence Entered
Apr 21, 2020
Correspondence Received In Law Office
Apr 21, 2020
Teas Response To Office Action Received
Mar 16, 2020
Notification Of Non-Final Action E-Mailed
Mar 16, 2020
Non-Final Action E-Mailed
Mar 16, 2020
Non-Final Action Written
Mar 12, 2020
Assigned To Examiner
Dec 20, 2019
Notice Of Design Search Code E-Mailed
Dec 19, 2019
New Application Office Supplied Data Entered
Dec 19, 2019
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24